Four legged citizens | Francis Battista | TEDxReno
President Barack Obama is no friend of press freedom, says a New York Times reporter who may be sent to jail for refusing to reveal a source. “A lot of people still think this is some kind of game or signal or spin,” reporter James Risen told his own paper in a profile about his plight published Saturday. “They don’t want to believe that Obama wants to crack down on the press and whistle-blowers. After many more years of legal fisticuffs, the Supreme Court announced in June that it would not take Risen’s appeal, leaving Risen out of legal options. Now Risen faces the specter of jail time if the Justice Department continues to insist that he reveal his source for the classified information.
Over the past five years, employers have reduced a variety of benefits, educational assistance and perks, according to a Society for Human Resource Management member survey of 510 human resources professionals. Less than a quarter (24 percent) of the employers SHRM surveyed continue to provide a traditional pension plan open to all employees. In contrast, 89 percent of the employers offer a 401(k) plan or similar type of retirement account, and most (74 percent) provide an employer contribution to the retirement account. “Fewer large employers provide a defined-benefit pension, shifting more of the responsibility for retirement to defined-contribution plans, which necessitates that employees be very active in the oversight and management of lifetime income,” says Shane Bartling, a retirement leader for Towers Watson in San Francisco.
US regulators on Monday put an experimental immunotherapy agent on the fast track to market approval, after 89 percent of leukemia patients in early trials saw their cancers disappear. The personalized immunotherapy known as CTL019 was developed by the University of Pennsylvania and was designated a “breakthrough therapy” by the US Food and Drug Administration. It is the first cancer immunotherapy to receive the breakthrough designation, and only the fifth biologic agent so far. The approach works by extracting a patient’s T-cells, then genetically programming them in the lab to target cancer cells that produce a protein called CD19.
Kelly Parker was thrilled when she landed her dream job in 2012 providing tech support for Harley-Davidson’s Tomahawk, Wisconsin, plants. The divorced mother of three hoped it was the beginning of a new career with the motorcycle company.
While it would be nice to think that managers are always 100 percent truthful and accurate when talking to employees, the reality is managers sometimes say things that aren’t quite true. So some employers are hesitant to grant special privileges in case a pattern emerges in who does and doesn’t receive those privileges, which can trigger concerns about this type of illegal discrimination.